Medicover AB (publ) provides healthcare and diagnostic services in Germany, Romania, Ukraine, Poland, Belarus, Moldova, Serbia, Turkey, Georgia, Bulgaria, Sweden, India, and Hungary.
Reasonable growth potential with mediocre balance sheet.
Share Price & News
How has Medicover's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: MCOV B has not had significant price volatility in the past 3 months.
7 Day Return
1 Year Return
Return vs Industry: MCOV B exceeded the Swedish Healthcare industry which returned 19% over the past year.
Return vs Market: MCOV B exceeded the Swedish Market which returned 21.6% over the past year.
Price Volatility Vs. Market
How volatile is Medicover's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 weeks ago | Simply Wall StAre Medicover's (STO:MCOV B) Statutory Earnings A Good Reflection Of Its Earnings Potential?
2 weeks ago | Simply Wall StAnalysts Are Updating Their Medicover AB (publ) (STO:MCOV B) Estimates After Its Second-Quarter Results
1 month ago | Simply Wall StIs Medicover (STO:MCOV B) A Risky Investment?
Is Medicover undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: MCOV B (SEK110.4) is trading below our estimate of fair value (SEK178.29)
Significantly Below Fair Value: MCOV B is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: MCOV B is poor value based on its PE Ratio (380x) compared to the SE Healthcare industry average (19.9x).
PE vs Market: MCOV B is poor value based on its PE Ratio (380x) compared to the Swedish market (22.9x).
Price to Earnings Growth Ratio
PEG Ratio: MCOV B is poor value based on its PEG Ratio (9.5x)
Price to Book Ratio
PB vs Industry: MCOV B is overvalued based on its PB Ratio (3.7x) compared to the SE Healthcare industry average (1.4x).
How is Medicover forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: MCOV B's forecast earnings growth (39.9% per year) is above the savings rate (0.5%).
Earnings vs Market: MCOV B's earnings (39.9% per year) are forecast to grow faster than the Swedish market (19.9% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: MCOV B's revenue (13.4% per year) is forecast to grow faster than the Swedish market (6.3% per year).
High Growth Revenue: MCOV B's revenue (13.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: MCOV B's Return on Equity is forecast to be low in 3 years time (11%).
How has Medicover performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: MCOV B has a large one-off loss of €11.1M impacting its June 30 2020 financial results.
Growing Profit Margin: MCOV B's current net profit margins (0.4%) are lower than last year (2.6%).
Past Earnings Growth Analysis
Earnings Trend: MCOV B's earnings have grown by 15.8% per year over the past 5 years.
Accelerating Growth: MCOV B's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: MCOV B had negative earnings growth (-80.4%) over the past year, making it difficult to compare to the Healthcare industry average (-31.8%).
Return on Equity
High ROE: MCOV B's Return on Equity (0.4%) is considered low.
How is Medicover's financial position?
Financial Position Analysis
Short Term Liabilities: MCOV B's short term assets (€283.7M) exceed its short term liabilities (€234.7M).
Long Term Liabilities: MCOV B's short term assets (€283.7M) do not cover its long term liabilities (€366.4M).
Debt to Equity History and Analysis
Debt Level: MCOV B's debt to equity ratio (42.7%) is considered high.
Reducing Debt: MCOV B's debt to equity ratio has reduced from 136.6% to 42.7% over the past 5 years.
Debt Coverage: MCOV B's debt is well covered by operating cash flow (60.5%).
Interest Coverage: MCOV B's interest payments on its debt are not well covered by EBIT (2x coverage).
What is Medicover current dividend yield, its reliability and sustainability?
Forecast Dividend Yield
Dividend Yield vs Market
Notable Dividend: Unable to evaluate MCOV B's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate MCOV B's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if MCOV B's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if MCOV B's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: MCOV B is not paying a notable dividend for the Swedish market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of MCOV B's dividend in 3 years as they are not forecast to pay a notable one for the Swedish market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Fredrik Rågmark (57 yo)
Mr. Fredrik Rågmark serves as the Group Chief Executive Officer of Medicover AB (publ). Mr. Rågmark has been employed with Medicover since 1996. He serves as Managing Director and Board Member of Kalvskär ...
CEO Compensation Analysis
Compensation vs Market: Fredrik's total compensation ($USD1.54M) is above average for companies of similar size in the Swedish market ($USD960.27K).
Compensation vs Earnings: Fredrik's compensation has been consistent with company performance over the past year.
|CEO & Director||no data||€1.31m||1.33% |
|Chief Financial Officer||no data||no data||0.78% |
|Chief Information Officer||0.83yr||no data||no data|
|Head of Investor Relations||no data||no data||no data|
|General Legal Counsel||no data||no data||0.011% |
|Chief Marketing Officer||no data||no data||no data|
|Group Human Resource Director||2.58yrs||no data||0.0018% |
|Chief Operating Officer of Healthcare Services||4.5yrs||no data||0.35% |
|Chief Operating Officer of Diagnostic Services||no data||no data||0.020% |
|Chief Executive Officer of Medicover Foundation||no data||no data||no data|
|Managing Director of Synevo Romania - Medicover Laboratory Services||no data||no data||no data|
|Managing Director of Hungary Operations||15.58yrs||no data||no data|
Experienced Management: MCOV B's management team is considered experienced (3.5 years average tenure).
|CEO & Director||no data||€1.31m||1.33% |
|Independent Director||13.58yrs||€48.00k||1.19% |
|Independent Chairman||3.58yrs||€85.00k||4.33% |
|Independent Director||19.58yrs||€58.00k||0.053% |
|Independent Director||19.58yrs||€51.00k||0.20% |
|Independent Director||5.58yrs||€67.00k||no data|
|Independent Director||8.58yrs||€48.00k||2.58% |
|Independent Director||3.58yrs||€58.00k||0.017% |
Experienced Board: MCOV B's board of directors are seasoned and experienced ( 11.1 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: MCOV B insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 11.2%.
Medicover AB (publ)'s company bio, employee growth, exchange listings and data sources
- Name: Medicover AB (publ)
- Ticker: MCOV B
- Exchange: OM
- Founded: 1995
- Industry: Health Care Services
- Sector: Healthcare
- Market Cap: kr16.376b
- Shares outstanding: 148.34m
- Website: https://www.medicover.com
Number of Employees
- Medicover AB (publ)
- PO Box 5283
- Stockholm County
- 102 46
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|5M0B||DB (Deutsche Boerse AG)||Yes||Class B Shares||DE||EUR||May 2017|
|0RPS||LSE (London Stock Exchange)||Yes||Class B Shares||GB||SEK||May 2017|
|MCOV B||OM (OMX Nordic Exchange Stockholm)||Yes||Class B Shares||SE||SEK||May 2017|
|MCOVBS||BATS-CHIXE (BATS 'Chi-X Europe')||Yes||Class B Shares||GB||SEK||May 2017|
|MCVE.Y||OTCPK (Pink Sheets LLC)||UNSPONSRED ADS||US||USD||Oct 2018|
Medicover AB (publ) provides healthcare and diagnostic services in Germany, Romania, Ukraine, Poland, Belarus, Moldova, Serbia, Turkey, Georgia, Bulgaria, Sweden, India, and Hungary. The company operates i ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/08/14 11:01|
|End of Day Share Price||2020/08/13 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.